Article Correctness Is Author's Responsibility: Anti-clotting drug could reduce ARDS deaths as a result of COVID-19

The article below may contain offensive and/or incorrect content.

This shows covid 19A new clinical trial is being established to see if anti-clotting drugs, commonly used for heart attack and stroke patients, can help treat COVID-19 patients who develop ARDS. If successful, the tPA drugs could help alleviate the expected ventilator shortage problem we are likely to experience soon.